Emily A Evans-Hoeker1, Esther Eisenberg2, Michael P Diamond3, Richard S Legro4, Ruben Alvero5, Christos Coutifaris6, Peter R Casson7, Gregory M Christman8, Karl R Hansen9, Heping Zhang10, Nanette Santoro5, Anne Z Steiner11. 1. Department of Obstetrics and Gynecology, Virginia Tech Carilion, Carilion Clinic, Roanoke, Virginia. Electronic address: eaevanshoeker@carilionclinic.org. 2. Fertility and Infertility Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland. 3. Department of Obstetrics and Gynecology, Georgia Regents University, Augusta, Georgia. 4. Department of Obstetrics and Gynecology, Pennsylvania State University, Hershey, Pennsylvania. 5. Department of Obstetrics and Gynecology, University of Colorado, Denver, Colorado. 6. Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 7. Department of Obstetrics and Gynecology, University of Vermont, Burlington, Vermont. 8. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. 9. Department of Obstetrics and Gynecology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma. 10. Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut. 11. Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina.
Abstract
OBJECTIVE: To determine if maternal major depression (MD), antidepressant use, or paternal MD are associated with pregnancy outcomes after non-IVF fertility treatments. DESIGN: Cohort study. SETTING: Clinics. PATIENT(S): Participants in two randomized trials: PPCOS II (clomiphene citrate versus letrozolefor polycystic ovary syndrome), and AMIGOS (gonadotropins versus clomiphene citrate versus letrozole for unexplained infertility). INTERVENTION(S): Female and male partners completed the Patient Health Questionnaire (PHQ-9). Female medication use was collected. PHQ-9 score ≥10 was used to define currently active MD. MAIN OUTCOME MEASURE(S): Primary outcome: live birth. SECONDARY OUTCOMES: pregnancy, first-trimester miscarriage. Poisson regression models were used to determine relative risks after adjusting for age, race, income, months trying to conceive, smoking, and study (PPCOS II versus AMIGOS). RESULT(S): Data for 1,650 women and 1,608 men were included. Among women not using an antidepressant, the presence of currently active MD was not associated with poorer fertility outcomes (live birth, miscarriage), but rather was associated with a slightly increased likelihood of pregnancy. Maternal antidepressant use (n = 90) was associated with increased risk of miscarriage, and male partners with currently active MD were less likely to achieve conception. CONCLUSION(S): Currently active MD in the female partner does not negatively affect non-IVF treatment outcomes; however, currently active MD in the male partner may lower the likelihood of pregnancy. Maternal antidepressant use is associated with first-trimester pregnancy loss, which may depend upon the type of antidepressant. CLINICAL TRIAL REGISTRATION NUMBERS: NCT00719186 and NCT01044862.
RCT Entities:
OBJECTIVE: To determine if maternal major depression (MD), antidepressant use, or paternal MD are associated with pregnancy outcomes after non-IVF fertility treatments. DESIGN: Cohort study. SETTING: Clinics. PATIENT(S): Participants in two randomized trials: PPCOS II (clomiphene citrate versus letrozole for polycystic ovary syndrome), and AMIGOS (gonadotropins versus clomiphene citrate versus letrozole for unexplained infertility). INTERVENTION(S): Female and male partners completed the Patient Health Questionnaire (PHQ-9). Female medication use was collected. PHQ-9 score ≥10 was used to define currently active MD. MAIN OUTCOME MEASURE(S): Primary outcome: live birth. SECONDARY OUTCOMES: pregnancy, first-trimester miscarriage. Poisson regression models were used to determine relative risks after adjusting for age, race, income, months trying to conceive, smoking, and study (PPCOS II versus AMIGOS). RESULT(S): Data for 1,650 women and 1,608 men were included. Among women not using an antidepressant, the presence of currently active MD was not associated with poorer fertility outcomes (live birth, miscarriage), but rather was associated with a slightly increased likelihood of pregnancy. Maternal antidepressant use (n = 90) was associated with increased risk of miscarriage, and male partners with currently active MD were less likely to achieve conception. CONCLUSION(S): Currently active MD in the female partner does not negatively affect non-IVF treatment outcomes; however, currently active MD in the male partner may lower the likelihood of pregnancy. Maternal antidepressant use is associated with first-trimester pregnancy loss, which may depend upon the type of antidepressant. CLINICAL TRIAL REGISTRATION NUMBERS: NCT00719186 and NCT01044862.
Authors: K Demyttenaere; L Bonte; M Gheldof; M Vervaeke; C Meuleman; D Vanderschuerem; T D'Hooghe Journal: Fertil Steril Date: 1998-06 Impact factor: 7.329
Authors: Yael I Nillni; Amelia K Wesselink; Jaimie L Gradus; Elizabeth E Hatch; Kenneth J Rothman; Ellen M Mikkelsen; Lauren A Wise Journal: Am J Obstet Gynecol Date: 2016-04-27 Impact factor: 8.661
Authors: Louis F Fabre; Anita H Clayton; Louis C Smith; Irwin M Goldstein; Leonard R Derogatis Journal: J Neuropsychiatry Clin Neurosci Date: 2013 Impact factor: 2.198
Authors: Lindsey A Sjaarda; Jeannie G Radoc; Kerry S Flannagan; Sunni L Mumford; Keewan Kim; Neil J Perkins; Robert M Silver; Enrique F Schisterman Journal: Fertil Steril Date: 2020-10-14 Impact factor: 7.329
Authors: Jennifer J Yland; Taiyao Wang; Zahra Zad; Sydney K Willis; Tanran R Wang; Amelia K Wesselink; Tammy Jiang; Elizabeth E Hatch; Lauren A Wise; Ioannis Ch Paschalidis Journal: Hum Reprod Date: 2022-03-01 Impact factor: 6.918
Authors: Pingsheng Wu; Digna R Velez Edwards; Phillip Gorrindo; Alexandra C Sundermann; Eric S Torstenson; Sarah H Jones; Ronna L Chan; Katherine E Hartmann Journal: Pharmacotherapy Date: 2019-07-25 Impact factor: 4.705
Authors: Jennifer J Yland; Michael L Eisenberg; Elizabeth E Hatch; Kenneth J Rothman; Craig J McKinnon; Yael I Nillni; Greg J Sommer; Tanran R Wang; Lauren A Wise Journal: Fertil Steril Date: 2021-05-07 Impact factor: 7.490
Authors: Ma-Li Wong; Mauricio Arcos-Burgos; Sha Liu; Alice W Licinio; Chenglong Yu; Eunice W M Chin; Wei-Dong Yao; Xin-Yun Lu; Stefan R Bornstein; Julio Licinio Journal: J Affect Disord Date: 2020-10-17 Impact factor: 6.533